N. Hillman et al., EFFICACY OF OCTREOTIDE IN THE REGRESSION OF A METASTATIC CARCINOID-TUMOR DESPITE NEGATIVE IMAGING WITH IN-111-PENTETREOTIDE (OCTREOSCAN), EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(3), 1998, pp. 226-230
We present the case of a 52-year old patient diagnosed with carcinoid
tumour of the rectum with liver metastases in which treatment with som
atostatin analogues (octreotide) proved very effective in the disappea
rance of the symptomatology and dramatic efficacy in the regression of
the tumour. Imaging by octreoscan was always negative. The role of oc
treotide in the treatment of carcinoid tumour and the usefulness of In
-111-pentetreotide (octreoscan) in the localization and prediction of
the response to treatment with octreotide is discussed. We conclude th
at the negative result of the scintigraphic image with octreoscan does
not necessarily suppose the inefficacy of octreotide treatment. We be
lieve that this may constitute an important issue since some patients
may be denied octreotide treatment in the absence of a positive octreo
scan result.